ABEONA THERAPEUTICS INC. Income Taxes Paid
ABEONA THERAPEUTICS INC. (ABEO) reported Income Taxes Paid of $7.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-17.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaidNet · last filed 2026-03-17
- ABEONA THERAPEUTICS INC. income taxes paid, net for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. income taxes paid, net for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- ABEONA THERAPEUTICS INC. income taxes paid, net for the quarter ending 2024-06-30 was -$1.00K.
- ABEONA THERAPEUTICS INC. income taxes paid, net for the quarter ending 2024-03-31 was $8.00K, a 33.33% increase year-over-year.
- ABEONA THERAPEUTICS INC. income taxes paid, net for fiscal 2024 was $7.00K, a 50.00% decline from fiscal 2023.
- ABEONA THERAPEUTICS INC. income taxes paid, net for fiscal 2023 was $14.00K.
| Period end | Income Taxes Paid, Net 3 month | Income Taxes Paid, Net 6 month | Income Taxes Paid, Net 9 month | Income Taxes Paid, Net 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-17 | $0.00 derived: sum of 2 quarters · filed 2026-03-17 | -$1.00K derived: sum of 3 quarters · filed 2026-03-17 | $7.00K 10-K · filed 2026-03-17 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | -$1.00K derived: sum of 2 quarters · filed 2025-11-12 | $7.00K 10-Q · filed 2025-11-12 | $14.00K derived: sum of 4 quarters · filed 2025-11-12 |
| 2024-06-30 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $7.00K 10-Q · filed 2025-08-14 | $14.00K derived: sum of 3 quarters · filed 2025-08-14 | $15.00K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $8.00K 10-Q · filed 2025-05-15 | $15.00K derived: sum of 2 quarters · filed 2025-05-15 | $16.00K derived: sum of 3 quarters · filed 2025-05-15 | $16.00K derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $8.00K derived: sum of 2 quarters · filed 2025-03-20 | $8.00K derived: sum of 3 quarters · filed 2025-03-20 | $14.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.00K derived: sum of 2 quarters · filed 2024-11-14 | $7.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $6.00K 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | $6.00K 10-Q · filed 2024-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |